Tandem Mass Spectrometry Assay for PPT1 and TPP1 Enzyme Activity in Dried Blood Spots
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for neuronal ceroid lipofuscinoses (NCLs) are inefficient and lack a fast, inexpensive, and reliable procedure for screening lysosomal enzyme activities in newborns, particularly for palmitoyl protein thioesterase 1 (PPT1) and tripeptidyl peptidase 1 (TPP1), which are crucial for early diagnosis and treatment of these neurodegenerative disorders.
Innovation Solution
Development of reagents and methods using tandem mass spectrometry for assaying PPT1 and TPP1 enzymes, involving specific substrates and internal standards that allow for quantitative enzyme activity measurements in dried blood spots, enabling simplex, duplex, or multiplex assays for accurate detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radiometric or fluorescence enzymatic assays are used for diagnosis, then detection sensitivity is improved, but cost and complexity increase
Solution Approach 1:
The patent replaces complex radiometric and fluorescence detection systems with tandem mass spectrometry, which provides simplified instrumentation while maintaining high detection sensitivity for enzyme activities in dried blood spots.
Solution Approach 2:
The invention changes the detection parameter from radiometric/fluorescence signals to mass-to-charge ratio measurements, enabling quantification of enzyme activities through specific substrate-product mass transitions detected by tandem mass spectrometry.
2Measurement precision
If traditional enzymatic assays are used, then diagnostic accuracy is improved, but screening speed and productivity decrease
Solution Approach 1:
The patent enables continuous high-throughput screening by automating the tandem mass spectrometry-based enzymatic assays, allowing rapid sequential analysis of multiple dried blood spots without the time-consuming manual steps required by traditional methods.
Solution Approach 2:
By changing from traditional detection parameters to mass spectrometry parameters, the method achieves both high diagnostic accuracy through specific mass transitions and high productivity through rapid data acquisition and automated analysis.
3Measurement precision
If specialized enzymatic assays are developed, then measurement precision is improved, but ease of operation and accessibility worsen
Solution Approach 1:
The patent develops a universal tandem mass spectrometry platform that can measure multiple lysosomal enzyme activities (PPT1, TPP1, and others) using the same instrumentation and methodology, making the high-precision assays accessible to broader newborn screening programs without requiring specialized equipment for each enzyme.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution provides a robust and cost-effective method for screening PPT1 and TPP1 activities, enhancing early diagnosis and treatment prospects for NCLs by improving the sensitivity and specificity of enzyme activity measurements in newborn screening.
Implementation Method 1
Several assays of lysosomal enzyme activities in DBS using tandem mass spectrometry and selected reaction monitoring (SRM) have previously been reported.
Implementation Method 2
PPT1 cleaves thioester-linked fatty acid groups from C-terminal cysteine residues in lipoproteins. TPP1 is a serine protease that cleaves three amino acid residues from unsubstituted protein N-termini.
Implementation Method 3
The fluorometric assay for PPT1, uses an S-palmitoyl-6-thiogalactosylcoumarin conjugate that requires a coupling enzyme to release the fluorescent 7-hydroxy-4-methylcoumarin for detection. The fluorometric assay for TPP1 uses Ala-Ala-Pro-7-amido-4-methylcoumarin that releases the fluorescent 7-amino-4-methylcoumarin upon enzymatic hydrolysis.
Implementation Method 4
The fluorometric assay for PPT1, uses an S-palmitoyl-6-thiogalactosylcoumarin conjugate that requires a coupling enzyme to release the fluorescent 7-hydroxy-4-methylcoumarin for detection.
Data Source
AI summary
The present disclosure provides assays for lysosomal enzymes, specifically palmitoyl protein thioesterase 1 (PPT1) and tripeptidyl peptidase 1 (TPP1), using, for example, tandem mass spectrometry. The assays involve the detection of enzymatic products obtained through the action of the lysosomal enzymes on new enzyme substrates, and can be used for quantitative enzyme activity measurements. The assays for the enzymes utilize a minimum steps for sample work up and can be run in a simplex format or in a duplex format for the detection of neuronal ceroid lipofuscinoses, or in a multiplex format with other mass spectrometry-based assays for screening of neuronal ceroid lipofuscinoses and other lysosomal storage disorders.